Amaris Elliott-Engel
The U.S. Court of Appeals for the Sixth Circuit has upheld a $5 million verdict issued in a mass tort in which plaintiffs alleged that GE Healthcare Inc. failed to warn that a gadolinium-based contrast agent used in MRIs can cause the growth of painful excess fibrous tissue in patients with failing kidneys.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
